myeloma

Welcome to the 'myeloma' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'myeloma'.

Latest blogosphere posts tagged “myeloma”

• ChemGenex Announces FDA Accepts NDA For Omapro™ (Omacetaxine Mepesuccinate) And Grants The Filing Priority Review Status

  
  Health News from Medical News Today — Authority: 738
  ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the U.S. Food & Drug Administration (FDA) has accepted the companys New Drug Application (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who ...
  15 hours ago

• Featured blog: Margaret’s Myeloma Blog

  
  Health Blogs at HealthBlogs.org — Authority: 91
  This myeloma blog covers a vast array of topics.  Readers will find material covering treatment, supportive care and well-written  explanations of various studies related to myeloma and health in general. The blog offers charming personal anectodes, fantastic photography from locations around Europe and the USA ...
  1 day ago

• Targeting PKC-theta Protein: A Way To Inhibit Harmful Immune Responses?

  
  Health News from Medical News Today — Authority: 738
  For some individuals with leukemia, the best treatment option is to receive a bone marrow transplant from a person who is not an identical genetic match. The donor bone marrow gives rise to immune cells that attack the leukemia (a response known as a graft-versus leukemia [GVL] response).
  1 day ago

• EpiCept Corporation Announces Health Canada Accepts Ceplene(R) Application For Review

  
  Health News from Medical News Today — Authority: 738
  EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Health Canada has accepted for review the Companys New Drug Submission (NDS) for Ceplene® (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission.
  1 day ago

• Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation

  
  Health News from Medical News Today — Authority: 738
  For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative ...
  4 days ago

• ERYtech Pharma Starts Its Pivotal Clinical Trial For GRASPA(R) In Acute Lymphoblastic Leukaemia

  
  Health News from Medical News Today — Authority: 738
  ERYtech Pharma announces the start of its pivotal clinical trial for GRASPA®, its lead product in Acute Lymphoblastic Leukaemia. This phase III trial has begun in France and will be enlarged to a European scale. Up to 80 patients with relapsed Acute Lymphoblastic Leukaemia, aged from 1 to 55 years old will be ...
  4 days ago

• FDA Approves Gloucester Pharmaceuticals ISTODAX(R) For Patients With Cutaneous T-cell Lymphoma

  
  Health News from Medical News Today — Authority: 738
  Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.
  4 days ago

• Steroid Pills effective for patients with Multiple Myeloma

  
  Anabolic Steroids Blog - iSteroids . com — Authority: 139
  According to researchers at the Cedars-Sinai Medical Center , steroid pill treatment can be highly effective when it comes to improving the overall survival rate of patients with multiple myeloma , a cancer of the plasma cells in the bone marrow . Multiple myeloma , which is considered to be a dreadful ...
  5 days ago

• Immune Therapy Can Protect Against Or Treat Later Lymphoma

  
  Health News from Medical News Today — Authority: 738
  Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection, said a group of researchers led by those from Baylor College of Medicine, The Methodist ...
  1 week ago

• Sunesis Completes Enrollment Of Voreloxin REVEAL-1 Trial In Acute Myeloid Leukemia

  
  Health News from Medical News Today — Authority: 738
  Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from ...
  1 week ago

• Immunotherapy Demonstrates Long-Term Success In Treating Lymphoma

  
  Health News from Medical News Today — Authority: 738
  Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue.
  1 week ago

• Lymphoma Research Foundation Announces Recipients Of CLL/SLL Research Initiative Grants

  
  Health News from Medical News Today — Authority: 738
  The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundations Chronic Lymphocytic Leukemia ...
  1 week ago

• Innovative National Clinical Trial Network Launched By Rare Cancer Charity

  
  Health News from Medical News Today — Authority: 738
  Myeloma UK has launched an innovative Clinical Trial Network designed to transform the way drugs for the bone marrow cancer myeloma are tested and accessed in the UK.
  1 week ago

• Lymphoma Patients Benefit From Exercise

  
  Health News from Medical News Today — Authority: 738
  A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.
  2 weeks ago

• FDA Approves New Treatment For Chronic Lymphocytic Leukemia

  
  Health News from Medical News Today — Authority: 738
  The U.S. Food and Drug Administration approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow. Arzerra is approved for patients with CLL whose cancer is no longer being controlled by other forms of chemotherapy.
  2 weeks ago

• Lower-Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

  
  Health News from Medical News Today — Authority: 738
  High-dose dexamethasone is a mainstay of therapy for multiple myeloma.
  2 weeks ago

• Pixantrone Produces High Rates Of Complete Remission In Multiple Relapsed And Refractory Indolent And Aggressive Non-Hodgkins Lymphoma

  
  Health News from Medical News Today — Authority: 738
  Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that Dr.
  2 weeks ago

• Millennium Initiates Phase II Trial For Diffuse Large B-Cell Lymphoma

  
  Health News from Medical News Today — Authority: 738
  Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common type of lymphoma.
  2 weeks ago

• Reunion ‘09: A Beer for Hope Launch Party

  
  BetterBeerBlog — Authority: 112
  Pete Slosberg, founder of Pete’s Wicked Ale, will be hosting the launch party for Reunion ‘09: A Beer for Hope at Firehouse Grill and Brewery on Wednesday, October 28, 2009 from 6pm to 9pm. For $10, receive a commemorative pint glass and beer. Additional beers will be $3. 50% of the proceeds from the sale [...]
  3 weeks ago

• Novartis Drug Tasigna(R) Meets Primary Endpoint In Pivotal Trial Against Gleevec(R) As First-line Treatment In Chronic Myeloid Leukemia Patients

  
  Health News from Medical News Today — Authority: 738
  Novartis announced that Tasigna® (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the companys groundbreaking drug Gleevec® (imatinib mesylate) tablets*.
  3 weeks ago

Comments about myeloma